NP / PA
Sun-Young, PLLC
Sun-Young, PLLC was paid $428K by Medicaid between Jan 2018 and Jul 2019, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 62% of everything it billed.
33Billing provider infoSUN-YOUNG, PLLC
COLUMBIA, TN 38401
COLUMBIA, TN 38401
33aNPI1871733667assigned 03/06/2009
33bProvider typeMedical Physician Assistant
28Total paid$428K
24GClaims28,275
24DCodes billed21
24AFirst – last monthJan 2018 – Jul 2019
Compared with peers
Next to other Medical Physician Assistant providers in Tennessee
Rank by total paid#5 of 62
Median peer was paid$13K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,967 | $250K | |
| 2019 | 10,308 | $179K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 62% | 15,697 | 12,807 | $265K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 13% | 2,425 | 2,109 | $57K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 1,751 | 1,443 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.8% | 4,080 | 3,412 | $38K |
| 80305 | 1.9% | 1,077 | 1,045 | $8K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 83 | 59 | $3K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 139 | 136 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 313 | 256 | $2K |
| 62370 | <1% | 85 | 72 | $2K | |
| 96103 | <1% | 477 | 320 | $1K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 601 | 412 | $1K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 604 | 415 | $1K |
9 more codes
| 76942 | <1% | 80 | $869.24 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 105 | $684.14 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 16 | $518.37 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 328 | $272.63 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 55 | $94.22 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 188 | $92.48 |
| 96146 | <1% | 134 | $25.77 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 23 | $5.48 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 14 | $1.94 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, DOUG (PARTNER)